ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
ERVK-18 |
|
endogenous retrovirus group K member 18
|
|
|
0.560 |
0.654 |
PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
DDX3X |
O00571
|
DEAD-box helicase 3 X-linked
|
|
1.00 |
0.537 |
0.769 |
TLR3 |
O15455
|
toll like receptor 3
|
Receptor
|
1.6E-07 |
0.427 |
0.885 |
ZMYND10 |
O75800
|
zinc finger MYND-type containing 10
|
|
2.3E-07 |
0.553 |
0.731 |
SEC14L2 |
O76054
|
SEC14 like lipid binding 2
|
|
2.9E-08 |
0.494 |
0.885 |
GLS |
O94925
|
glutaminase
|
Enzyme
|
0.96 |
0.489 |
0.808 |
DDX58 |
O95786
|
DExD/H-box helicase 58
|
|
1.8E-23 |
0.526 |
0.808 |
OAS1 |
P00973
|
2'-5'-oligoadenylate synthetase 1
|
Enzyme
|
3.4E-05 |
0.626 |
0.654 |
TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
CSF1R |
P07333
|
colony stimulating factor 1 receptor
|
Kinase
|
0.13 |
0.448 |
0.808 |
IFIT2 |
P09913
|
interferon induced protein with tetratricopeptide repeats 2
|
|
0.25 |
0.656 |
0.500 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
SPP1 |
P10451
|
secreted phosphoprotein 1
|
|
2.1E-06 |
0.353 |
0.885 |